We’re working to bring the hope of advanced medicine to more patients.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Researchers focus on reversing the scarring that’s common to liver diseases.

The head of Public Affairs for the Novartis Malaria Initiative has a malaria story of her own to tell.

Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

Bertrand Bodson explains the Novartis strategy for digital innovation in asthma care.

Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's been a lack of progress in finding more effective medications. Advances in understanding mean new options for patients and caregivers.

Hundreds of millions of people worldwide await treatments for rare diseases.

Van der Kamp explains how leading by example has encouraged others to adopt flexible working models.

Gschwentner and Lackner discuss the advantages of their job share.